U.S. Representative Tulsi Gabbard
Governor David Ige
State Senator Roz Baker (Maui)
Former State Senator and County Councilor Gary Hooser (Kaua’i)
Mayoral Candidate and former County Councilor Mel Rapozo (Kaua’i)
Civil Beat Writer Anita Hofschneider
Civil Beat Writer John Hill
Vice President / Editor Star Advertiser Frank Bridgewater
City Editor Star Advertiser David Butts
Mahalo for the discussion and input. I truly appreciate all views in this issue, especially those based on factual information as you always provide. Thanks again. ~ Mel Rapozo
STUDY: ADHD Drugs Can Lead to Psychosis in Some
Following up my earlier article about cannabis and psychosis, a new study to be released today reports medication prescribed to teens and young people with attention deficit hyperactivity disorder (ADHD) could face an increased risk of psychosis with certain drugs. And, as I wrote about cannabis … key words are COULD FACE.
The study showed the development of psychosis appeared in people who had recently begun taking the amphetamines.
The study, conducted by researchers at McLean Hospital and Harvard Medical School, looked at young people who had recently begun taking two classes of drugs — amphetamines (marketed as Adderall and Vyvanse) and methylphenidates (marketed as Ritalin or Concerta) — used to treat ADHD.
The study showed that while the chance of developing psychosis — a condition that affects the mind and causes a person to lose contact with reality — is low, there is an increased risk of developing the disorder in patients taking the amphetamines.
Clinicians have long observed “patients without previous psychiatric history” developing psychosis “in the setting of stimulant use.”
The study, which was funded by the National Institutes of Health, looked at insurance claims on more than 220,000 ADHD patients between the ages of 13 and 25 years old who had started taking amphetamines or methylphenidate between Jan. 1, 2004, and Sept. 30, 2015.
The marijuana study I discussed earlier examined two groups — 900 test and 1200 control subjects, which is a small number for a complex research project. This study was funded by the National Institutes of Health and examined insurance claims on more than 220,000 ADHD patients between the ages of 13 and 25 years old who had started taking amphetamines or methylphenidate between Jan. 1, 2004, and Sept. 30, 2015.
According to the study, researchers found that one out of every 486 patients started on an amphetamine developed psychosis that required treatment with antipsychotic medication. One in 1,046 patients started on methylphenidate developed psychosis.
According to the study, researchers found one out of every 486 patients started on an amphetamine developed psychosis that required treatment with antipsychotic medication.
One in 1,046 patients started on methylphenidate developed psychosis.
This isn’t simply association. These results suggest CAUSATION …
Why do we hold compassionate Medical Cannabis users to such a standard of perfection? Why would we strip a person of their livelihood and employment for using medical cannabis?
Here we see our keiki at risk due to ADHD drugs. Will this article make the front page of the Star Advertiser? Will it? Will it? Please leave your comments below and be sure to FOLLOW ClearHeath Life Strategies. We provide News of the News You Wish You Knew.